CEO SUMMARY: With so many market forces working against the economic interests of clinical laboratories, it is essential that all labs develop appropriate strategies designed to sustain the quality of laboratory testing services and the financial integrity of the laboratory organization. In this intelligence briefing, XIFIN, Inc.’s CEO, Lâle White, explains five strategies that are […]
CEO Offers Lab Strategies for a Post-PAMA World
It’s not just PAMA price cuts to Medicare fees, but narrow networks, pre-authorization, and more
- By Joseph Burns
- > From the Volume XXVI No. 1 - January 14, 2019 Issue
- Tags: billing system, cap, clfs, clinical laboratories, Clinical Laboratory, Clinical Laboratory Fee Schedule, clinical labs, lab industry, lab test, lab test prices, lab testing, lab tests, laboratories, laboratory fee schedule, laboratory testing, laboratory testing services, Lale White, Medicare, Medicare Fee Cuts, pathologists, private payer, revenue cycle, revenue cycle management, revenue cycle management services, the laboratory, workflow automation, xifin
